Integration properties of wharton's jelly-derived novel mesenchymal stem cells into ventricular slices of murine hearts

Cellular Physiology and Biochemistry

Volumn 28, Issue 1, 2011, Pages 63-76

  Lupu, Marilena ^a   Khalil, Markus ^b   Andrei, Eugen ^a   Iordache, Florin ^a   Pfannkuche, Kurt ^b   Neef, Klaus ^b   Georgescu, Adriana ^a,c   Buzila, Cosmin ^a   Brockmeier, Konrad ^b   Maniu, Horia ^a   Hescheler, Jürgen ^b  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b UNIVERSITY OF COLOGNE   (Germany)

^c PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

Author keywords

Cardiac ischemia; Cellular integration; In vitro transplantation; Novel mesenchymal stem cells; Ventricular slices; Wharton's jelly

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE TRIPHOSPHATE; CD146 ANTIGEN; CD31 ANTIGEN; ENDOGLIN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CHEMOTAXIS; COCULTURE; COLONY FORMING CELL; CONTROLLED STUDY; EMBRYO; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROSCOPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD; WESTERN BLOTTING; WHARTON JELLY;

MURINAE;

EID: 80051984523     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000331714     Document Type: Article

References (60)

1. Thomas ED, Storb R: Development of the Scientific Foundation of Hematopoietic Cell Transplantation Based on Animal and Human Studies, in: Thomas ED, Blume KG, Forman S (Eds.): Hematopoietic Cell Transplantation, Blackwell Publishing, 1999, pp 1-11.
2. Pillekamp F, Khalil M, Emmel M, Brockmeier K, Hescheler J: Stem cells in pediatric heart failure. Minerva Cardioangiol 2008;56:335-348. (Pubitemid 351946762)
3. Pesce M, Orlandi A, Iachininoto MG, Straino S, Torella AR, Rizzuti V, Pompilio G, Bonanno G, Scambia G, Capogrossi MC: Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 2003;93:e51-e62.
4. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402. (Pubitemid 32522033)
5. Dengler TJ, Katus HA: Stem cell therapy for the infarcted heart ("cellular cardiomyoplasty"). Herz 2002;27:598-610. (Pubitemid 35415247)
6. Henning RJ, Bu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR: Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004;13:729-739. (Pubitemid 40280210)
7. Kim BO, Tian H, Prasongsukarn K, Wu J, Angoulvant D, Wnendt S, Muhs A, Spitkovsky D, Li RK: Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005;112:I96-104. (Pubitemid 41266659)
8. Pereira WC, Khushnooma I, Madkaikar M, Ghosh K: Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J Tissue Eng Regen Med 2008;2:394-399.
9. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004;10:494-501. (Pubitemid 38667908)
10. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK: Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007;110:1362-1369. (Pubitemid 47281438)
11. Troyer DL, Weiss ML: Wharton's jellyderived cells are a primitive stromal cell population. Stem Cells 2008;26:591-599.
12. Anzalone R, Iacono ML, Corrao S, Magno F, Loria T, Cappello F, Zummo G, Farina F, La Rocca G: New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 2010;19:423-438.
13. Fong CY, Richards M, Manasi N, Biswas A, Bongso A: Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online 2007;15:708-718. (Pubitemid 350285987)
14. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D: Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006;24:781-792. (Pubitemid 44464783)
15. Kadam SS, Tiwari S, Bhonde RR: Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. In Vitro Cell Dev Biol Anim 2009;45:23-27.
16. Seshareddy K, Troyer D, Weiss ML: Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol 2008;86:101-119.
17. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004;22:1330-1337.
18. Can A, Karahuseyinoglu S: Concise Review: Human Umbilical Cord Stroma with Regard to the Source of Fetus-Derived Stem Cells. Stem Cells 2007;25:2886-2895. (Pubitemid 350127873)
19. Wang SH, Lin SJ, Chen YH, Lin FY, Shih JC, Wu CC, Wu HL, Chen YL: Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor. Arterioscler Thromb Vasc Biol 2009;29:816-822.
20. Alaminos M, Perez-Kohler B, Garzon I, Garcia-Honduvilla N, Romero B, Campos A, Bujan J: Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J Cell Physiol 2010;223:640-647.
21. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR: Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008;26:2865-2874.
22. Hou T, Xu J, Wu X, Xie Z, Luo F, Zhang Z, Zeng L: Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering. Tissue Eng Part A 2009;15:2325-2334.
23. Wang L, Tran I, Seshareddy K, Weiss ML, Detamore MS: A Comparison of Human Bone Marrow-Derived Mesenchymal Stem Cells and Human Umbilical Cord-Derived Mesenchymal Stromal Cells for Cartilage Tissue Engineering. Tissue Eng Part A 2009;15:2259-2266.
24. Conconi MT, Burra P, Di Liddo R, Calore C, Turetta M, Bellini S, Bo P, Nussdorfer GG, Parnigotto PP: CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 2006;18:1089-1096.
25. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, Shih YH, Hung SC, Fu YS: The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 2009;15:484-495.
26. Chan RW, Rodriguez ML, McFetridge PS: The human umbilical vein with Wharton's jelly as an allogeneic, acellular construct for vocal fold restoration. Tissue Eng Part A 2009;15:3537-3546.
27. Chen MY, Lie PC, Li ZL, Wei X: Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 2009;37:629-640.
28. Schmidt D, Mol A, Odermatt B, Neuenschwander S, Breymann C, Gossi M, Genoni M, Zund G, Hoerstrup SP: Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng 2006;12:3223-3232. (Pubitemid 44846426)
29. Wu KH, Zhou B, Yu CT, Cui B, Lu SH, Han ZC, Liu YL: Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 2007;83:1491-1498. (Pubitemid 46454258)
30. Sys SU, De Keulenaer GW, Brutsaert DL: Reappraisal of the multicellular preparation for the in vitro physiopharmacological evaluation of myocardial performance. Adv Exp Med Biol 1998;453:441-450.
31. Beeres SL, Atsma DE, van der Laarse A, Pijnappels DA, van Tuyn J, Fibbe WE, de Vries AA, Ypey DL, van der Wall EE, Schalij MJ: Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J Am Coll Cardiol 2005;46:1943-1952. (Pubitemid 41579820)
32. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148. (Pubitemid 38891685)
33. Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, Stoecker E, Fleischmann M, Bohlen H, Stehle R, Kolossov E, Brem G, Addicks K, Pfitzer G, Welz A, Hescheler J, Fleischmann BK: Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002;105:2435-2441. (Pubitemid 34556398)
34. Pillekamp F, Reppel M, Dinkelacker V, Duan Y, Jazmati N, Bloch W, Brockmeier K, Hescheler J, Fleischmann BK, Koehling R: Establishment and characterization of a mouse embryonic heart slice preparation. Cell Physiol Biochem 2005;16:127-132. (Pubitemid 41199910)
35. Pillekamp F, Halbach M, Reppel M, Rubenchyk O, Pfannkuche K, Xi JY, Bloch W, Sreeram N, Brockmeier K, Hescheler J: Neonatal murine heart slices A robust model to study ventricular isometric contractions. Cell Physiol Biochem 2007;20:837-846. (Pubitemid 350059726)
36. Halbach M, Pillekamp F, Brockmeier K, Hescheler J, Muller-Ehmsen J, Reppel M: Ventricular slices of adult mouse hearts-a new multicellular in vitro model for electrophysiological studies. Cell Physiol Biochem 2006;18:1-8.
37. Pillekamp F, Reppel M, Rubenchyk O, Pfannkuche K, Matzkies M, Bloch W, Sreeram N, Brockmeier K, Hescheler J: Force measurements of human embryonic stem cell-derived cardiomyocytes in an in vitro transplantation model. Stem Cells 2007;25:174-180. (Pubitemid 46052988)
38. Lupu M, Khalil M, Iordache F, Andrei E, Pfannkuche K, Spitkovsky D, Baumgartner S, Rubach M, Abdelrazik H, Buzila C,Brockmeier K, Simionescu M, Hescheler J, Maniu H: Direct Contact of Umbilical Cord Blood Endothelial Progenitors with Living Cardiac Tissue is a Requirement for Vascular Tube-like Structures Formation. J Cell Mol Med 2010, in press.
39. Xi J, Khalil M, Shishechian N, Hannes T, Pfannkuche K, Liang H, Fatima A, Haustein M, Suhr F,Bloch W, Reppel M, Saric T, Wernig M, Janisch R, Brockmeier K, Hescheler J, Pillekamp F: Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J 2010;24:2739-2751.
40. Popov D, Simionescu M, Shepherd PR: Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters. Diabetologia 2003;46:1408-1418. (Pubitemid 37297212)
41. Lugus JJ, Chung YS, Mills JC, Kim SI, Grass J, Kyba M, Doherty JM, Bresnick EH, Choi K: GATA2 functions at multiple steps in hemangioblast development and differentiation. Development 2007;134:393-405.
42. Debacker C, Catala M, Labastie MC: Embryonic expression of the human GATA-3 gene. Mech Dev 1999;85:183-187. (Pubitemid 29355093)
43. Jiang Y, Drysdale TA, Evans T: A role for GATA-4/5/6 in the regulation of Nkx25 expression with implications for patterning of the precardiac field. Dev Biol 1999;216:57-71.
44. Eriksson U, Alitalo K: VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies. Nat Med 2002;8:775-777.
45. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S: High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007;100:204-212. (Pubitemid 46208720)
46. Meng E, Guo Z, Wang H, Jin J, Wang J, Wang H, Wu C, Wang L: High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev 2008;17:805-813.
47. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317. (Pubitemid 44269669)
48. Xu J, Wang W, Kapila Y, Lotz J, Kapila S: Multiple differentiation capacity of STRO-1+/CD146+ PDL mesenchymal progenitor cells. Stem Cells Dev 2009:18:487-496.
49. Covas DT, Panepucci RA, Fontes AM, Silva WA, Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC, Zago MA: Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 2008;36:642-654.
50. Gnecchi M, Zhang Z, Ni A, Dzau VJ: Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204-1219.
51. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, Xu M, Zhu Y, Ashraf M, Wang Y: Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 2008:44:281-292.
52. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209. (Pubitemid 44427444)
53. Botta R, Gao E, Stassi G, Bonci D, Pelosi E, Zwas D, Patti M, Colonna L, Baiocchi M, Coppola S, Ma X, Condorelli G, Peschle C: Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J 2004;18:1392-1394. (Pubitemid 39561591)
54. Ott I, Keller U, Knoedler M, Gotze KS, Doss K, Fischer P, Urlbauer K, Debus G, von Bubnoff N, Rudelius M, Schomig A, Peschel C, Oostendorp RA: Endotheliallike cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 2005;19:992-994. (Pubitemid 40827728)
55. Ten Brinke EA, Klautz RJ, Tulner SA, Verwey HF, Bax JJ, Schalij MJ, van der Wall EE, Versteegh MI, Dion RA, Steendijk P: Long-term effects of surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting on left ventricular function: Six-month followup by pressure-volume loops. J Thorac Cardiovasc Surg 2010;140:1338-1344.
56. Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF: The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 1999;44:232-241. (Pubitemid 29474084)
57. McCurdy S, Baicu CF, Heymans S, Bradshaw AD: Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). J Mol Cell Cardiol 2010;48:544-549.
58. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT: Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005;97:8-15. (Pubitemid 40982317)
59. Eisenberg CA, Burch JB, Eisenberg LM: Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart. Stem Cells 2006;24:1236-1245. (Pubitemid 44464692)
60. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E: Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLAidentical sibling Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Eng J Med 2000;342:1846-1854.